This article was automatically generated by Dow Jones using technology from Automated Insights.

The following companies are among those expected to report their latest financial results before the market opens.

$Aramark(ARMK-W)$'s second-quarter EPS is forecast at 43 cents, compared with 23 cents in the prior-year period. Adjusted EPS is forecast at 47 cents.

Zebra Technologies Corp.'s first-quarter EPS is forecast at $2.81, compared with $2.62 in the prior-year period. Adjusted EPS is forecast at $4.25.

Middleby Corp.'s first-quarter EPS is forecast at $2.13, compared with $1.99 in the prior-year period. Adjusted EPS is forecast at $2.32.

Legend Biotech Corp. ADR's first-quarter EPS is forecast at 1 cent, compared with a loss of 54 cents in the prior-year period.

Under Armour Inc.'s fourth-quarter EPS is forecast at a loss of 7 cents, compared with a loss of 16 cents in the prior-year period. Adjusted EPS is forecast at a loss of 2 cents.

Ducommun Inc.'s first-quarter EPS is forecast at 57 cents, compared with 69 cents in the prior-year period. Adjusted EPS is forecast at 68 cents.

Vestis Corp.'s second-quarter EPS is forecast at $0.00, compared with a loss of 21 cents in the prior-year period. Adjusted EPS is forecast at 8 cents.

MeiraGTx Holdings PLC's first-quarter EPS is forecast at a loss of 17 cents, compared with a loss of 51 cents in the prior-year period. Adjusted EPS is forecast at a loss of 61 cents.

Vishay Precision Group Inc.'s first-quarter EPS is forecast at a loss of 2 cents. Adjusted EPS is forecast at 0 cents.

Janus International Group Inc.'s first-quarter EPS is forecast at 6 cents, compared with 8 cents in the prior-year period. Adjusted EPS is forecast at 9 cents.

Arvinas Inc.'s first-quarter EPS is forecast at a loss of 92 cents, compared with net income of $1.14 per share in the prior-year period.

Candel Therapeutics Inc.'s first-quarter EPS is forecast at a loss of 24 cents, compared with net income of 13 cents per share in the prior-year period. Adjusted EPS is forecast at a loss of 30 cents.

XOMA Royalty Corp.'s first-quarter EPS is forecast at 17 cents, compared with 6 cents in the prior-year period.

Lifeway Foods Inc.'s first-quarter EPS is forecast at 30 cents, compared with 23 cents in the prior-year period.

Zentalis Pharmaceuticals Inc.'s first-quarter EPS is forecast at a loss of 48 cents, compared with a loss of 67 cents in the prior-year period.

Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.

(END) Dow Jones Newswires

May 12, 2026 05:31 ET (09:31 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.